Repurposing Antipsychotics for Cancer Treatment

Cancer is a leading cause of death worldwide, with approximately 19 million new cases each year. Lately, several novel chemotherapeutic drugs have been introduced, efficiently inhibiting tumor growth and proliferation. However, developing a new drug is a time- and money-consuming process, requiring...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Nikolaos Vlachos, Marios Lampros, Spyridon Voulgaris, George A. Alexiou
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	cancer antipsychotics repurposing
Online Access:	https://www.mdpi.com/2227-9059/9/12/1785

Similar Items

Editorial: Drug repurposing for cancer treatment: current and future directions
by: Marios Lampros, et al.
Published: (2025-02-01)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
by: Michele Persico, et al.
Published: (2022-01-01)

Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
by: Marina Caldara, et al.
Published: (2021-09-01)

Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
by: Bálint Rácz, et al.
Published: (2023-01-01)

Psychotropic drug repurposing for COVID-19: a systematic review
by: U. Isayeva, et al.
Published: (2022-06-01)

The Role of Hsp27 in Chemotherapy Resistance
by: Marios Lampros, et al.
Published: (2022-04-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence
by: Zheng Gao, et al.
Published: (2022-12-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
by: Silvia Matteoni, et al.
Published: (2021-02-01)

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions
by: Eleni Sertedaki, et al.
Published: (2020-05-01)

Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Research progress in drug repurposing in the treatment of breast cancer
by: TAN Chen, et al.
Published: (2024-11-01)

Repurposing of the Drug Tezosentan for Cancer Therapy
by: Eduarda Ribeiro, et al.
Published: (2023-06-01)

Stereotactic radiosurgery versus whole-brain radiotherapy after resection of solitary brain metastasis: A systematic review and meta-analysis
by: Nikolaos Vlachos, et al.
Published: (2023-04-01)

REPURPOSING DRUGS FOR CANCER THERAPY
by: Ege Arzuk, et al.
Published: (2022-08-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
by: A. González-Rodríguez, et al.
Published: (2021-04-01)

Comparative Analysis of Time to All-cause Treatment Discontinuation and Rehospitalization among Early-phase Schizophrenia Patients Discharged on Long-acting Injectable Antipsychotics versus Oral Antipsychotics
by: Ta-Chun Lin, et al.
Published: (2025-01-01)

Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and Glioblastoma
by: Catarina Moura, et al.
Published: (2025-07-01)

Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021-10-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
by: Filipa Moreira-Silva, et al.
Published: (2020-04-01)

Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01)

antipsychotics and metabolic syndrome
by: R. Jomli, et al.
Published: (2022-06-01)

Informatics on Drug Repurposing for Breast Cancer
by: Zhou H, et al.
Published: (2023-06-01)

Lomitapide repurposing for treatment of malignancies: A promising direction
by: Hua-Tao Wu, et al.
Published: (2024-06-01)

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

Genomic strategies for drug repurposing
by: Kirtan Dave, et al.
Published: (2024-11-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

Intellectual disability and antipsychotics
by: I. Cuevas Iñiguez, et al.
Published: (2021-04-01)

Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs
by: Ljubica Vucicevic, et al.
Published: (2018-10-01)

Mechanism-based inhibition of squalene epoxidase by phenothiazines for lipid metabolism disruption using repurposed antipsychotic drugs
by: Emadeldin M. Kamel, et al.
Published: (2025-10-01)

Melatonin as a Repurposed Drug for Melanoma Treatment
by: Rachana Pathipaka, et al.
Published: (2023-01-01)

Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer
by: Ana Luísa De Sousa-Coelho, et al.
Published: (2023-12-01)

Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
by: Zixun Wang, et al.
Published: (2025-03-01)